Elvira Bramon-Bosch

My research focuses on biological markers of psychosis risk and their genetic basis. I have conducted extensive EEG experiments in patients with schizophrenia and bipolar disorder as well as populations at risk of developing these diseases. I have worked using family as well as twin designs. Other biomarkers I'm interested in include MRI and cognition as well as how these different markers relate to each other to model psychosis risk. I use these EEG, cognitive and MRI biomarkers as alternative phenotypes (in addition to a conventional case-control analysis) to identify genes involved in the risk of developing psychosis. I have published a number of candidate gene studies of the phenotypes described. More recently, in collaboration with colleagues across Europe and Australia, I am doing a genome wide association study (GWAS) as part of the Wellcome Trust Case Control Consortium and I am also starting work on a low coverage whole genome sequencing project in psychosis and its characteristic phenotypes.

Schizophrenia, bipolar disorder, populations at psychosis risk, psychiatric genetics, EEG, cognition MRI, biomarkers for psychosis, endophenotypes, family/twin study